Effectiveness of SmartGuard Technology in the Prevention of Nocturnal Hypoglycemia After Prolonged Physical Activity

Diabetes Technology & Therapeutics
Lenka PetruželkováBarbora Obermannova

Abstract

The prevention of postexercise nocturnal hypoglycemia after prolonged physical activity using sensor-augmented pump (SAP) therapy with predictive low-glucose management (PLGM) has not been well studied. We conducted a study at a pediatric diabetes camp to determine whether a SAP with PLGM reduces the frequency of nocturnal hypoglycemia after prolonged physical activity more effectively than a SAP with a carbohydrate intake algorithm. During a 1-week sport camp, 20 children (aged 10-13 years) with type 1 diabetes (T1D) managed by SAP therapy either with (n = 7) or without PLGM (n = 13) were studied. The hypoglycemia management strategy and the continuous glucose monitoring (CGM)/PLGM settings were standardized. The incidence, severity, and duration of hypoglycemia and carbohydrate intake were documented and compared. The PLGM system was activated on 78% of all nights (once per night on average). No difference was found between the SAP and PLGM groups in the mean overnight glucose curve or mean morning glucose (7.8 ± 2 mmol/L vs. 7.4 ± 3 mmol/L). There was no difference in the frequency and severity of hypoglycemia. However, the SAP group consumed significantly more carbohydrates to prevent and treat hypoglycemia than those in th...Continue Reading

References

Oct 18, 2005·The Journal of Pediatrics·Eva TsalikianUNKNOWN Diabetes Research In Children Network Direcnet Study Group
Aug 12, 2008·Diabetes Care·Anne-Sophie BrazeauHortensia Mircescu
Sep 17, 2009·Pediatric Diabetes·Kenneth RobertsonMichael C Riddell
Oct 17, 2009·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Robert J TanenbergAlmond J Drake
Oct 24, 2009·Diabetes Technology & Therapeutics·Bruce BuckinghamH Peter Chase
Mar 5, 2010·Diabetes Care·UNKNOWN Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
Jul 24, 2010·The Journal of Pediatrics·Craig E TaplinRosanna Fiallo-Scharer
Jan 5, 2011·Diabetes, Obesity & Metabolism·I W GallenA Lumb
Aug 11, 2011·Diabetes Technology & Therapeutics·Thomas DanneAndreas Thomas
Feb 10, 2012·Diabetes Technology & Therapeutics·Satish GargFrancine R Kaufman
Jun 25, 2013·The New England Journal of Medicine·Richard M BergenstalUNKNOWN ASPIRE In-Home Study Group
Dec 10, 2013·Diabetes Care·Naama Barnea-GoralyUNKNOWN Diabetes Research in Children Network (DirecNet)
May 9, 2014·Diabetes Care·David M MaahsUNKNOWN In Home Closed Loop Study Group
Jun 8, 2015·Diabetes Care·Bruce A BuckinghamUNKNOWN In Home Closed Loop Study Group
Feb 26, 2016·Diabetes Technology & Therapeutics·Pratik ChoudharyJohn J Shin
Mar 1, 1988·The Physician and Sportsmedicine·R StrattonR K Endres
Aug 10, 2016·Diabetes Technology & Therapeutics·Mary B AbrahamElizabeth A Davis

❮ Previous
Next ❯

Citations

Jan 23, 2018·Diabetic Medicine : a Journal of the British Diabetic Association·D KerrD C Klonoff
Oct 5, 2018·Diabetes Technology & Therapeutics·Lenka PetruzelkovaBarbora Obermannova
Jul 25, 2019·Diabetes Technology & Therapeutics·Stefan PleusGuido Freckmann
Feb 14, 2018·Diabetes Technology & Therapeutics·Tadej Battelino, Bruce W Bode
May 16, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Jothydev KesavadevGopika Krishnan
Jul 8, 2020·International Journal of Sports Medicine·Mikołaj KamińskiDorota Zozulinska-Ziolkiewicz

❮ Previous
Next ❯

Software Mentioned

R

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.